Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)

NCT00684203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis
Myocardial Ischemia
Myocardial Infarction

Interventions

DRUG: Vorapaxar
DRUG: Placebo
DRUG: Aspirin
DRUG: Clopidogrel

Sponsor

Merck Sharp & Dohme LLC